Detalhe da pesquisa
1.
The Evolving Treatment Landscape of Medullary Thyroid Cancer.
Curr Treat Options Oncol
; 24(12): 1815-1832, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-37979019
2.
Androgen serum levels in male patients with adrenocortical carcinoma given mitotane therapy: A single center retrospective longitudinal study.
Front Endocrinol (Lausanne)
; 14: 1128061, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37077359
3.
Feasibility and Activity of Megestrol Acetate in Addition to Etoposide, Doxorubicin, Cisplatin, and Mitotane as First-Line Therapy in Patients with Metastatic/Unresectable Adrenocortical Carcinoma with Low Performance Status.
Cancers (Basel)
; 15(18)2023 Sep 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37760461
4.
Supportive therapies in patients with advanced adrenocortical carcinoma submitted to standard EDP-M regimen.
Endocrine
; 77(3): 438-443, 2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-35567656
5.
Advances in adrenocortical carcinoma pharmacotherapy: what is the current state of the art?
Expert Opin Pharmacother
; 23(12): 1413-1424, 2022 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-35876101